The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats

Journal of Neuroscience

Volumn 22, Issue 22, 2002, Pages 9980-9989

  Raghavendra, Vasudeva ^a   Rutkowski, Maria D ^a   Deleo, Joyce A ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Glia; Hyperalgesia; Interleukin 1 ; Interleukin 6; Morphine tolerance; Neuropathy; Tumor necrosis factor

Indexed keywords

CYTOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MORPHINE; NARCOTIC ANALGESIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; DRUG WITHDRAWAL; GLIA CELL; HYPERALGESIA; IMMUNE RESPONSE; INFLAMMATION; LUMBAR SPINAL CORD; MALE; MORPHINE TOLERANCE; NERVE TRANSECTION; NEUROIMMUNOLOGY; NEUROPATHIC PAIN; NEUROPATHY; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SPINAL NERVE;

EID: 0037112041     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-22-09980.2002     Document Type: Article

References (48)

1. Aloisi F (2001) Immune function of microglia. Glia 36:165-179.
2. Arruda JL, Sweitzer S, Rutkowski MD, DeLeo JA (2000)Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: Possible immune modulation in neuropathic pain. Brain Res 879:216-225.
3. Backonja MM, Miletic G, Miletic V (1995) The effect of continuous morphine analgesia on chronic thermal hyperalgesia due to sciatic constriction injury in rats. Neurosci Lett 96:61-64.
4. Bars DL, Gozariu M, Cadden SW (2001) Animal models of nociception. Pharmacol Rev 53:597-652.
5. Beitner-Johnson D, Guitart X, Nestler EJ (1993) Glial fibrillary acidic protein and the mesolimbic dopamine system: Regulation by chronic morphine and Lewis-Fisher strain differences in the rat ventral tegmental area. J Neurochem 61:1766-1773.
6. Bian D, Ossipov MH, Ibrahim M, Raffa RB, Tallarida RJ, Malan Jr TP, Lai J, Porreca F (1999) Loss of antiallodynic and antinociceptive spinal/supraspinal morphine svnergy in nerve-injured rats: Restoration by MK-801 or dynorphine antiserum. Brain Res 831:55-63.
7. Catheline G Kayser V, Guilbaud G (1996) Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: Involvement of κ-, but not δ-opioid receptors. Eur J Pharmacol 315:135-143.
8. Chao CC, Gekker G, Sheng WS, Hu S, Monica T, Peterson PK (1994) Priming effect of morphine on the production of tumor necrosis factor-α by microglia: Implications in respiratory burst activity and human immunodeficiency virus-1 expression. J Pharmacol Exp Ther 269:198-203.
9. Chao HJ, Basbaum AI (1989) Ultrastructural analysis of dynorphin B-immunoreactive cells and terminals in the superficial dorsal horn of the deafferented spinal cord of the rat. J Comp Neurol 281:193-205.
10. Cherny NI, Thaler HT, Friedlander-Klar H, Lapin J, Foley KM, Houde R, Portenoy RK (1994) Opioid responsiveness of cancer pain syndrome caused by neuropathic or nociceptive mechanisms: A combined analysis of controlled, single-dose studies. Neurology 44:857-861.
11. Christensen D, Kayser V (2000) The development of pain-related behavior and opioid tolerance after neuropathy-inducing surgery and sham surgery. Pain 88:231-238.
12. Colburn RW, Rickman AJ, DeLeo JA (1999) The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp Neurol 157:289-304.
13. Covino BG, Dubner R, Gybels J, Losterlitz HW, Liebeskind JC, Sternbach RA, Vylicky L, Yamamura H, Zimmerman M (1980) Ethical standards for investigations of experimental pain in animals. Pain 9:141-143.
14. DeLeo JA, Yezierski RP (2001) The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90:1-6.
15. Devulder J, Bohyn P, Castille F, De Laat M, Rolly G (1996) A case of uncommon withdrawal symptoms after a short period of spinal morphine administration. Pain 64:589-591.
16. Dong Y, Benveniste EN (2001) Immune function of astrocytes. Glia 36:180-190.
17. Dubner R, Ruda MA (1992) Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci 15:96-103.
18. Fundytus ME, Yashpal K, Chabot JG, Osborne MG, Lefebvre CD, Dray A, Henry JL, Coderre TJ (2001) Knockdown of spinal metabotropic glutamate receptor 1 (mGluR(1)) alleviates pain and restores opioid efficacy after nerve injury in rats. Br J Pharmacol 132:354-367.
19. Gul H, Yildiz O, Dogrul A, Yesilyurt O, Isimer A (2000) The interaction between IL-1β and morphine: Possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice. Pain 89:39-45.
20. Ji RR, Baba H, Brenner GJ, Woolf CJ (1999) Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci 2:1114-1119.
21. Kontny E, Ziolkowska M, Ryzewska A, Maslinski W (1998) Protein kinase C dependent pathway is critical for the production of proinflammatory cytokines (TNF-α, IL-1β, IL-6). Cytokines 11:839-848.
22. Kreutzberg GW (1996) Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
23. Laughlin TM, Bethea JR, Yezierski RP, Wilcox GL (2000) Cytokine involvement in dynorphin-induced allodynia. Pain 84:159-167.
24. Li X, Angst MS, Clark JD (2001a) A murine model of opioid-induced hyperalgesia. Brain Res Mol Brain Res 86:56-62.
25. Li X, Angst MS, Clark JD (2001b) Opioid-induced hyperalgesia and incisional pain. Anesth Analg 93:204-209.
26. Ma W, Zheng WH, Powell K, Jhamandas K, Quirion R (2001) Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: An in vitro and in vivo study. Eur J Neurosci 14:1091-1104.
27. Mao J, Price DD, Mayer DJ (1995) Experimental mononeuropathy reduces the antinociceptive effects of morphine: Implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 61:353-364.
28. Mayer DJ, Mao J, Holt J, Price DD (1999) Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci USA 96:7731-7736.
29. McCormack K, Prather P, Chapleo C (1998) Some new insight into the effects of opioids in phasic and tonic nociceptive test. Pain 78:79-98.
30. Milligan ED, O'Connor KA, Nguyen KT, Armstrong CB, Twining C, Gaykema R, Holguin A, Martin D, Maier SF, Watkins LR (2001) Intrathecal HIV-1 envelope glycoprotein gpl20 enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci 21:2808-2819.
31. Nichols ML, Lopez Y, Ossipov MH, Bian D, Porreca F (1997) Enhancement of the anti allodynic and anti nociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK801 in a nerve-ligation model peripheral neuropathy. Pain 69:317-322.
32. Nozaki-Taguchi N, Yaksh TL (2002) Spinal and peripheral mu opioids and the development of secondary tactile allodynia after thermal injury. Anesth Analg 94:968-974.
33. Oka T, Hori T (1999) Brain cytokines and pain. In: Cytokines and Pain (Watkins LR, Maier SF, eds), pp 183-203. Boston: Birkhauser Verlag.
34. Peterson PK, Molitor TW, Chao CC (1998) The opioid-cytokine connection. J Neuroimmunol 83:63-69.
35. Przewlocki R, Przewlocka B (2001) Opioids in chronic pain. Eur J Pharmacol 429:79-91.
36. 1β in mice. J Pharmacol Exp Ther 299:659-665.
37. Raffa RB, Mathiasen JR, Kimball ES, Vaught JL (1993) The combined immunological and antinociceptive defects of beige-J mice: The possible existence of a "mu-repression." Life Sci 52:1-8.
38. Rattan AK, Tejwani GA (1997) Effect of chronic treatment with morphine, midazolam and both together on dynorphin (1-13) level in the rat. Brain Res 754:239-244.
39. Rausch O, Newton RA, Bingham S, Macdonald R, Case CP, Sanger GJ, Lawson SN, Reith AD (2000) Nerve injury-associated kinase: A sterile 20-like protein kinase up-regulated in dorsal root ganglia in a rat model of neuropathic pain. Neuroscience 101:767-777.
40. Song P, Zhao Z-Q (2001) The involvement of glial cells in the development of morphine tolerance. Neurosci Res 39:281-286.
41. Stein C, Gramsch C, Herz A (1990) Intrinsic mechanisms of antinociception in inflammation: Local opioid receptors and β-endorphin. J Neurosci 10:1292-1298.
42. Sweitzer SM, Arruda JL, DeLeo JA (2001a) The cytokine challenge: Methods for the detection of central cytokines in rodent models of persistent pain. In: Methods in Pain Research (Kruger L, ed), pp 109-132. New York: CRC.
43. Sweitzer S, Martin D, DeLeo JA (2001b) Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 103:529-539.
44. Vanderah TW, Gardell LR, Burgess SE, Ibrahim M, Dorgul A, Zhong C, Zhang E, Malan Jr PT, Ossipov MH, Lai J, Porreca F (2000) Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci 20:7074-7079.
45. Wang J, Charboneau R, Balasubramanian S, Barke RA, Loh HH, Roy S (2002) The immunosuppressive effects of morphine treatment are partially dependent on corticosterone and mediated by the μ-opioid receptor. J Leukoc Biol 71:782-790.
46. Watkins LR, Milligan ED, Maier SF (2001a) Glial activation: A driving force for pathological pain. Trends Neurosci 24:450-455.
47. Watkins LR, Milligan ED, Maier SF (2001b) Spinal cord glia: New player in pain. Pain 93:201-205.
48. Wegert S, Ossipov MH, Nicholas ML, Bian D, Vanderah TW, Malan Jr TP, Porreca F (1997) Differential activities of intrathecal MK801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats. Pain 71:57-64.